Does Dr. ARASH AGHEL have financial conflicts of interest?

Dr. ARASH AGHEL (M.D) has received a total of $3,177 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,177 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ARASH AGHEL?

According to CMS Open Payments data, Dr. ARASH AGHEL received funding from EDWARDS LIFESCIENCES CORPORATION ($657), BOSTON SCIENTIFIC CORPORATION ($309), and PHILIPS ELECTRONICS NORTH AMERICA CORPORATION ($254).

Does Dr. ARASH AGHEL receive research grants or speaking fees?

Dr. ARASH AGHEL has received $3,177 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ARASH AGHEL

M.DReal-Time Hydrated

Specialty: Internal Medicine, Interventional Cardiology

Practice Location: TORRANCE, CA 90505

NPI Number: 1477729713

LIFETIME INDUSTRY VALUE

$3,177

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AGHEL is a verified Internal Medicine, Interventional Cardiology practitioner based in TORRANCE, CA.

Between 2021 and 2024, Dr. AGHEL had an overall industry promotional and research financial footprint of $3,177 as recorded in the federal CMS Open Payments database.

$3,177 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGHEL's primary funding source is EDWARDS LIFESCIENCES CORPORATION, which accounts for $657 (representing 20.7% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

EDWARDS LIFESCIENCES CORPORATION

Rank 1

$657

20.7%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$309

9.7%

PHILIPS ELECTRONICS NORTH AMERICA CORPORATION

Rank 3

$254

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.